These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
415 related articles for article (PubMed ID: 14723168)
1. If foreign drug prices go up, will U.S. prices come down? Med Health; 2003 Dec; 57(45):2-4. PubMed ID: 14723168 [No Abstract] [Full Text] [Related]
2. Medicare should bargain for lower drug prices, study says. Med Health; 2005 Oct; 59(36):1, 3, 7. PubMed ID: 16240494 [No Abstract] [Full Text] [Related]
3. Prescription drug pricing: the consumer perspective. Searing A N C Med J; 2003; 64(6):300-2. PubMed ID: 14983625 [No Abstract] [Full Text] [Related]
5. Should drug prices be negotiated under part D of Medicare? And if so, how? Frank RG; Newhouse JP Health Aff (Millwood); 2008; 27(1):33-43. PubMed ID: 18180478 [TBL] [Abstract][Full Text] [Related]
6. PBMs to the rescue? Pharmacy benefit managers will play a key role in the Medicare drug benefit. What does it mean for the industry, consumers and Uncle Sam? Fong T Mod Healthc; 2005 Nov; 35(48):26-8, 30. PubMed ID: 16617721 [No Abstract] [Full Text] [Related]
7. Drug card setback highlights need for cost relief. Gundling RL Healthc Financ Manage; 2003 Apr; 57(4):50-4. PubMed ID: 12735187 [TBL] [Abstract][Full Text] [Related]
8. Prescription drug prices in Canada. Gross D Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2003 Jun; (IB62):1-22. PubMed ID: 12807123 [No Abstract] [Full Text] [Related]
9. Toward a rational, value-based drug benefit for Medicare. Lopert R; Moon M Health Aff (Millwood); 2007; 26(6):1666-73. PubMed ID: 17978385 [TBL] [Abstract][Full Text] [Related]
10. The Medicare prescription drug plan: assisting our older patients. Klein MN ORL Head Neck Nurs; 2004; 22(4):34-5. PubMed ID: 15617318 [TBL] [Abstract][Full Text] [Related]
11. Industry warily eyes new Medicare drug plan. Vastag B Nat Biotechnol; 2006 Feb; 24(2):120. PubMed ID: 16465141 [No Abstract] [Full Text] [Related]
12. Managed care cost containment involving prescription drugs. American Medical Association, Council on Ethical and Judicial Affairs. Food Drug Law J; 1998; 53(1):25-34. PubMed ID: 11795334 [No Abstract] [Full Text] [Related]
13. The need for health care reform. Mossinghoff GJ Health Syst Rev; 1994; 27(3):5-6. PubMed ID: 10134516 [No Abstract] [Full Text] [Related]
14. Barrier to trade or barrier to profit? Why Australia's Pharmaceutical Benefits Scheme worries U.S. drug companies. Hamilton C; Lokuge B; Denniss R Yale J Health Policy Law Ethics; 2004; 4(2):373-85. PubMed ID: 15536919 [No Abstract] [Full Text] [Related]
15. The Medicare Prescription Drug, Improvement, and Modernization Act of 2003. Emmer S; Allendorf L J Am Geriatr Soc; 2004 Jun; 52(6):1013-5. PubMed ID: 15161471 [No Abstract] [Full Text] [Related]
16. Economic grand rounds: potential effects of the new medicare drug benefit on pricing for psychotropic medications. Huskamp HA; Shinogle JA Psychiatr Serv; 2005 Sep; 56(9):1056-8. PubMed ID: 16148317 [No Abstract] [Full Text] [Related]
17. A first look at the new Medicare prescription drug plans. Frakt AB; Pizer SD Health Aff (Millwood); 2006; 25(4):W252-61. PubMed ID: 16720588 [TBL] [Abstract][Full Text] [Related]
18. The pharmaceutical industry--prices and progress. Scherer FM N Engl J Med; 2004 Aug; 351(9):927-32. PubMed ID: 15329432 [No Abstract] [Full Text] [Related]
19. Senate GOP tosses drug bill. Law would have let Medicare negotiate costs directly. DoBias M Mod Healthc; 2007 Apr; 37(17):12. PubMed ID: 17479495 [No Abstract] [Full Text] [Related]
20. State and federal government mandates are changing the face of pharmacy management. Giaquinta D Manag Care Interface; 2001 May; 14(5):50-2. PubMed ID: 11385948 [No Abstract] [Full Text] [Related] [Next] [New Search]